Glenmede Trust CO Na Agios Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $9,132 - $12,798	-275 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $1,558 - $2,572	46 Added 20.09%	275 $9,000
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $5,064 - $7,861	-147 Reduced 39.1%	229 $12,000
Q4 2019 Feb 12, 2020	BUY	$30.08 - $50.59 $10,497 - $17,655	349 Added 1292.59%	376 $17,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $874 - $1,338	27 New	27 $0
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $11,250 - $16,579	-245 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $10,468 - $18,749	245 New	245 $11,000
Q3 2018 Nov 15, 2018	SELL	$71.67 - $91.95 $55,902 - $71,721	-780 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$73.22 - $99.55 $57,111 - $77,649	780 New	780 $66,000

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.